Denali Therapeutics (DNLI) Retained Earnings (2017 - 2026)
Denali Therapeutics (DNLI) reported Retained Earnings of -$682000.0 for Q1 2026, down 133.48% year-over-year from $2.0 million in Q1 2025, and up 99.97% quarter-over-quarter from -$2.1 billion in Q4 2025.
Denali Therapeutics (DNLI) Retained Earnings (2017 - 2026) Analysis & Trends
Denali Therapeutics (DNLI) has 10 years of Retained Earnings data on file, last reported at -$682000.0 in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$682000.0, down 133.48% year-over-year; the trailing twelve-month figure through Mar 2026 was -$682000.0 (down 133.48% YoY), and the FY2025 annual result was -$2.1 billion, down 33.3% from the prior year.
- Retained Earnings climbed to -$682000.0 in Q1 2026 per DNLI's latest filing, from -$2.1 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $2.0 million in Q1 2025 and troughed at -$2.1 billion in Q4 2025.
- A 5-year average of -$674.4 million and a median of -$769.0 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2022 and 2025: Retained Earnings plunged 208870.11% in 2022, then jumped 257.18% in 2025.
- A 5-year view of Retained Earnings shows it stood at -$6.9 million in 2022, then tumbled by 16109.86% to -$1.1 billion in 2023, then plunged by 37.88% to -$1.5 billion in 2024, then plunged by 33.3% to -$2.1 billion in 2025, then jumped by 99.97% to -$682000.0 in 2026.
- Business Quant data shows DNLI's Retained Earnings at -$682000.0 in Q1 2026, -$2.1 billion in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Denali Therapeutics | 4.35 Bn | 4.35 Bn | - | -682,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -682,000.00 |
| Dec 31, 2025 | -2.05 Bn |
| Sep 30, 2025 | 1.10 Mn |
| Jun 30, 2025 | 939,000.00 |
| Mar 31, 2025 | 2.04 Mn |
| Dec 31, 2024 | -1.54 Bn |
| Sep 30, 2024 | -1.42 Bn |
| Jun 30, 2024 | -2.66 Mn |
| Mar 31, 2024 | -1.30 Mn |
| Dec 31, 2023 | -1.12 Bn |
| Sep 30, 2023 | -996.74 Mn |
| Jun 30, 2023 | -897.39 Mn |
| Mar 31, 2023 | -1.08 Bn |
| Dec 31, 2022 | -6.89 Mn |
| Sep 30, 2022 | -872.31 Mn |
| Jun 30, 2022 | -769.01 Mn |
| Mar 31, 2022 | -710.22 Mn |
| Dec 31, 2021 | -2.50 Mn |
| Sep 30, 2021 | -521,000.00 |
| Jun 30, 2021 | -368,000.00 |